Literature DB >> 8421169

Genes involved in Haemophilus influenzae type b capsule expression are frequently amplified.

P G Corn1, J Anders, A K Takala, H Käyhty, S K Hoiseth.   

Abstract

The genes involved in Haemophilus influenzae type b capsule expression are present as a duplication of an approximately 18-kb DNA segment (the Cap b locus). It has been shown previously that recombination occurs between the two copies of the repeat, resulting in deletion of one copy and loss of capsule expression at frequencies of 0.1%-0.5%. The present study tested the hypothesis that the duplicated arrangement could serve as a template for further amplification of capsule gene sequences. Southern hybridization analysis of 66 type b invasive isolates showed that amplifications exist and are moderately common (23/66 were amplified). In addition to three copies of the 18-kb repeat, four copies were detected in some strains, and up to five copies in 1 isolate. By ELISA, a five-copy strain made about six times more capsular polysaccharide than did an isogenic two-copy derivative. The evolutionary significance of the duplicated arrangement may be its ability to rapidly amplify under conditions where it is advantageous to produce more capsule.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8421169     DOI: 10.1093/infdis/167.2.356

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

Review 1.  Haemophilus influenzae: genetic variability and natural selection to identify virulence factors.

Authors:  Janet R Gilsdorf; Carl F Marrs; Betsy Foxman
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

2.  Detection of six copies of the capsulation b locus in a Haemophilus influenzae type b strain isolated from a splenectomized patient with fulminant septic shock.

Authors:  Marina Cerquetti; Rita Cardines; Maria Giufrè; Annalisa Castella; Monica Rebora; Paola Mastrantonio; Marta Luisa Ciofi Degli Atti
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

Review 3.  Antigenic diversity and gene polymorphisms in Haemophilus influenzae.

Authors:  J R Gilsdorf
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

4.  Effect of amplification of the Cap b locus on complement-mediated bacteriolysis and opsonization of type b Haemophilus influenzae.

Authors:  G J Noel; A Brittingham; A A Granato; D M Mosser
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

5.  Differences in surface expression of NspA among Neisseria meningitidis group B strains.

Authors:  G R Moe; S Tan; D M Granoff
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

6.  Invasive type e Haemophilus influenzae disease in Italy.

Authors:  Marina Cerquetti; Marta Luisa Ciofi degli Atti; Rita Cardines; Stefania Salmaso; Giovanna Renna; Paola Mastrantonio
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

7.  Complete sequence of the cap locus of Haemophilus influenzae serotype b and nonencapsulated b capsule-negative variants.

Authors:  Sarah W Satola; Patricia L Schirmer; Monica M Farley
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

8.  Capsule gene analysis of invasive Haemophilus influenzae: accuracy of serotyping and prevalence of IS1016 among nontypeable isolates.

Authors:  Sarah W Satola; Julie T Collins; Ruth Napier; Monica M Farley
Journal:  J Clin Microbiol       Date:  2007-08-15       Impact factor: 5.948

9.  Low genetic diversity of Haemophilus influenzae type b compared to nonencapsulated H. influenzae in a population in which H. influenzae is highly endemic.

Authors:  H C Smith-Vaughan; K S Sriprakash; A J Leach; J D Mathews; D J Kemp
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

10.  Discrete amplifiable regions (amplicons) in the symbiotic plasmid of Rhizobium etli CFN42.

Authors:  D Romero; J Martínez-Salazar; L Girard; S Brom; G Dávilla; R Palacios; M Flores; C Rodríguez
Journal:  J Bacteriol       Date:  1995-02       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.